Literature DB >> 28569361

Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing?

Inês Correia-Sá1,2,3, Paula Serrão4, Marisa Marques5,6, Maria A Vieira-Coelho4.   

Abstract

BACKGROUND: Hypertrophic scars are a consequence of wound healing.
OBJECTIVE: The objective of the present study is to evaluate vitamin D and inflammatory biomarker plasma levels during wound healing.
METHODS: A prospective study was performed in patients (n = 63) submitted to body contouring surgery. Blood samples were collected before (t 0) and 5 days after surgery (t 5). Blood cell count, protein inflammatory biomarkers, and circulating plasma levels of 25(OH)D, vitamin A and vitamin E were quantified. Six months after surgery, scars were evaluated and classified as normal or hypertrophic.
RESULTS: At the end of the study, 73% of the patients developed a normal scar (control group, n = 46) and 27% of the patients presented hypertrophic scars (HT group, n = 17). The patients in the HT group presented higher eosinophil (0.145 × 109 /L vs. 0.104 × 109 /L, p = 0.028) and basophil count (0.031 × 109 /L vs. 0.22 × 109 /L, p = 0.049) and C-reactive protein levels (6.12 mg/L vs. 2.30 mg/L, p = 0.015) in t 0 than the patients in the control group. At t 5, the patients in the HT group showed a decrease in neutrophil (3.144 × 109/L vs. 4.03 × 109/L, p = 0.031) and an increase in basophil (0.024 × 109/L vs. 0.015 × 109/L, p = 0.005) and lymphocyte count (1.836 × 109 /L vs. 1.557 × 109/L; p = 0.028). Before surgery, vitamin D plasma levels were found to be decreased by almost 50% (23.52 ng/mL vs. 15.46 ng/mL, p = 0.031) in the patients who developed hypertrophic scars. Thirty-one percent of the patients submitted to bariatric surgery had more hypertrophic scars, versus 24% of the patients with no previous bariatric surgery.
CONCLUSION: There is a different systemic inflammatory profile response in the patients during the formation of hypertrophic scars. Vitamin D plasma levels are marked reduced in these patients. Considering the powerful anti-inflammatory effect of vitamin D, these findings could be related.

Entities:  

Keywords:  Bariatric; Hypertrophic; Inflammation; Scar; Vitamin D; Wound healing

Mesh:

Substances:

Year:  2017        PMID: 28569361     DOI: 10.1007/s11695-017-2740-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  58 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  A novel immunosuppressive 1alpha,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity.

Authors:  Ulrich Zügel; Andreas Steinmeyer; Claudia Giesen; Khusru Asadullah
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

3.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid.

Authors:  W E Stumpf; M Sar; F A Reid; Y Tanaka; H F DeLuca
Journal:  Science       Date:  1979-12-07       Impact factor: 47.728

4.  25-Hydroxyvitamin D [25(OH)D] levels and diabetic foot ulcer: is there any relationship?

Authors:  Mohammad Zubair; Abida Malik; Dilnasheen Meerza; Jamal Ahmad
Journal:  Diabetes Metab Syndr       Date:  2013-07-20

5.  Epidermal participation in post-burn hypertrophic scar development.

Authors:  T E Hakvoort; V Altun; R S Ramrattan; T H van der Kwast; R Benner; P P van Zuijlen; A F Vloemans; E P Prens
Journal:  Virchows Arch       Date:  1999-03       Impact factor: 4.064

6.  Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin.

Authors:  R U Simpson; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

7.  Effect of Mederma on hypertrophic scarring in the rabbit ear model.

Authors:  Alexandrina S Saulis; Jon H Mogford; Thomas A Mustoe
Journal:  Plast Reconstr Surg       Date:  2002-07       Impact factor: 4.730

8.  Topical calcipotriol for preventive treatment of hypertrophic scars: a randomized, double-blind, placebo-controlled trial.

Authors:  Willem M van der Veer; Xander E Jacobs; Ingmar E Waardenburg; Magda M Ulrich; Frank B Niessen
Journal:  Arch Dermatol       Date:  2009-11

9.  Production and secretion of platelet-derived growth factor AB by cultured human keratinocytes: regulatory effects of phorbol 12-myristate 13-acetate, etretinate, 1,25-dihydroxyvitamin D3, and several cytokines.

Authors:  J Z Zhang; K Maruyama; I Ono; F Kaneko
Journal:  J Dermatol       Date:  1995-05       Impact factor: 4.005

Review 10.  Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

Authors:  Luciano Adorini; Giuseppe Penna; Nadia Giarratana; Milan Uskokovic
Journal:  J Cell Biochem       Date:  2003-02-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.